Texas Medical Center Venture Fund (TMCVF) is the venture capital arm of Texas Medical Center Corporation, funded through the corporation. It backs early-stage healthcare companies developing digital health tools, medical devices and therapeutics, from pre-seed through Series A. Alongside capital, the platform helps founders engage with the Texas Medical Center’s clinical, research and commercialization ecosystem. Its healthcare investments include medical-device engineering, diagnostics, neuroscience and AI-enabled care and operations tools. Launched in 2017, the fund operates as an evergreen investment programme; the current website reports USD75 million, while a separately dated March 29, 2022 announcement reported its expansion from USD25 million to USD50 million.
Founded
2017
Type
Venture capital
Funds1
TMC Venture Fund (evergreen)—$75M
Evergreen healthcare venture fund funded through Texas Medical Center Corporation. It invests from pre-seed through Series A in digital health, medical devices and therapeutics, supporting founders with the Texas Medical Center’s clinical and commercialization ecosystem. It launched in 2017 with USD25 million and was publicly expanded to USD50 million on March 29, 2022. Its current website reports USD75 million; the date of the expansion to that current capital scale is not established. This is a continuing corporate evergreen programme, not a newly verified 2023–2026 external fundraising close.
Enterprise Ireland
Nua Surgical€6M · 2024-12-06
EQT Life Sciences
Kidron Capital